Genfit S a
Officers & Directors
Genfit SA is a French biopharmaceutical company specializing in the development of innovative therapies for liver and metabolic diseases.
Pascal Prigent - CEO
Dean Hum - CFO
David Bejker - Chief Medical Officer
Jean-Francois Mouney - Chairman of the Board
Jean-Marc Huet - Director
Philippe Moity - Director
Dimitri Dimitriou - Director
Philippe Jacon - Director
Catherine Larue - Director
Here are brief biographies of each:
Pascal Prigent: Mr. Prigent has over 20 years of experience in the healthcare industry. Prior to joining Genfit, he held various senior positions at Sanofi, including Senior Vice President of Global Commercial Operations, and General Manager of Sanofi Pasteur Japan. He has also worked for Novo Nordisk and Eli Lilly.
Dean Hum: Mr. Hum has over 20 years of experience in finance and accounting. Prior to joining Genfit, he was CFO at Clementia Pharmaceuticals, where he played a key role in the company's successful IPO. He has also held senior finance positions at AmorChem II, Aptalis Pharma, and Axcan Pharma.
David Bejker: Dr. Bejker has over 15 years of experience in clinical development and medical affairs. Prior to joining Genfit, he was Vice President of Clinical Development at Intercept Pharmaceuticals, where he led the development of Ocaliva for the treatment of primary biliary cholangitis. He has also held senior positions at GlaxoSmithKline and Pfizer.
Jean-Francois Mouney: Mr. Mouney co-founded Genfit in 1999 and has served as Chairman of the Board since 2001. He has over 25 years of experience in the biotech industry and has held various executive positions at Genfit, including CEO and CFO. Prior to founding Genfit, he worked for Arthur Andersen and Ernst & Young.
Jean-Marc Huet: Mr. Huet has over 30 years of experience in finance and accounting. He was previously CFO of Unilever and has also held senior finance positions at Royal Numico, Cadbury Schweppes, and PepsiCo.
Philippe Moity: Mr. Moity has over 30 years of experience in the pharmaceutical industry. He was previously Senior Vice President and General Manager of Sanofi's Diabetes Division and has also held senior positions at AstraZeneca and GlaxoSmithKline.
Dimitri Dimitriou: Mr. Dimitriou has over 25 years of experience in the biotech industry. He was previously CEO of Erytech Pharma and has also held senior positions at Intercell and Merck Serono.
Philippe Jacon: Mr. Jacon has over 30 years of experience in the pharmaceutical industry. He was previously CEO of Pierre Fabre Medicament and has also held senior positions at Sanofi and Bristol-Myers Squibb.
Catherine Larue: Ms. Larue has over 25 years of experience in the biotech industry. She was previously Chief Financial Officer of Innate Pharma and has also held senior finance positions at Ipsen and Sanofi.
Genfit S a currently has 139 employees.
|
